Clinical Trial Update: Monoclonal Antibody Treatment of Crohn's Disease [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 clinical trial evaluating a monoclonal antibody treatment for Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Monoclonal antibody treatment (Phase 1 trial)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED